<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css" Rel="stylesheet" Type="text/css">
 <META name="description" content="Androg&egrave;nes et st&eacute;ro&iuml;des anabolisants">
 <META name="keywords" content="Androg&egrave;nes et st&eacute;ro&iuml;des anabolisants, R&eacute;pertoire Comment&eacute; des M&eacute;dicaments (C.B.I.P. aslb)">
 <META name="GGR_Kruimelpad" content=" Systeme hormonal / Hormones sexuelles / ">
 <META name="GGR_HyrTree" content="5.3.5.">
 <cfinclude template="/include/SPC.cfm"/>
  <script SRC="/JS/jquery-1.3.2.min.js"></script>
  <script SRC="/JS/jquery.qtip-1.0.0-rc3.min.js"></script>
  <!---script SRC="/JS/qTip_FR.js"></script--->
 <TITLE>Androg&egrave;nes et st&eacute;ro&iuml;des anabolisants</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0" id="bodykw">
 <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 

 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD vAlign="top" Width="260">
  <!--- begin van linker "tafel" met TOC --->
    <TABLE Width="260" Border="0" CellPadding="0" CellSpacing="0" BgColor="#DEFFD6" style="border: solid #000000 1px">
     <TR>
      <TD ColSpan="3" Align="center" BgColor="#008000">
       <FONT Face="Arial" Size="2" Color="#FFFFFF"><STRONG>Table des mati&egrave;res</STRONG></FONT></TD>
     </TR>
     <TR>
      <TD Width="3">&nbsp;</TD>
      <TD Width="256">
       <TABLE Width="100%" Border="0" CellPadding="2" CellSpacing="0">
        <TR>
         <TD  Colspan="2"><IMG SRC="../Images/Pixel_Transp.gif" Alt="" Width="1" Height="5" Border="0"></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">&nbsp;</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="/GGR/Index_Intro.cfm" Class="toc">Introduction</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_A.htm" Class="toc">Syst&egrave;me cardio-vasculaire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_B.htm" Class="toc">Sang et coagulation</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_C.htm" Class="toc">Syst&egrave;me gastro-intestinal</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_D.htm" Class="toc">Syst&egrave;me respiratoire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_E.htm" Class="toc">Syst&egrave;me hormonal</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.3.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_EC.htm" Class="toc">&nbsp;Hormones sexuelles</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr" BgColor="#FFFF99">5.3.5.</TD>
         <TD vAlign="top" Class="toc" BgColor="#FFFF99">&nbsp;&nbsp;Androg&egrave;nes et st&eacute;ro&iuml;des anabolisants</TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.3.5.1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_ECEA" Class="toc">&nbsp;&nbsp;&nbsp;Mest&eacute;rolone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.3.5.2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_ECEB" Class="toc">&nbsp;&nbsp;&nbsp;Nandrolone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.3.5.3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_ECEC" Class="toc">&nbsp;&nbsp;&nbsp;Testost&eacute;rone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">6.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_F.htm" Class="toc">Gyn&eacute;co-obst&eacute;trique</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">7.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_G.htm" Class="toc">Syst&egrave;me urog&eacute;nital</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">8.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_H.htm" Class="toc">Douleur et fi&egrave;vre</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">9.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_I.htm" Class="toc">Pathologies ost&eacute;o-articulaires</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_J.htm" Class="toc">Syst&egrave;me nerveux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">11.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_K.htm" Class="toc">Infections</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">12.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_L.htm" Class="toc">Immunit&eacute;</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">13.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_M.htm" Class="toc">M&eacute;dicaments antitumoraux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">14.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_N.htm" Class="toc">Min&eacute;raux, vitamines et toniques</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">15.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_O.htm" Class="toc">Dermatologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">16.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_P.htm" Class="toc">Ophtalmologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">17.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_Q.htm" Class="toc">Oto-Rhino-Laryngologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">18.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_R.htm" Class="toc">Anesth&eacute;sie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">19.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_S.htm" Class="toc">Agents de diagnostic</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">20.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_T.htm" Class="toc">M&eacute;dicaments divers</A><BR>
         </TD>
        </TR>
       </TABLE>
       <BR>
      </TD>
     </TR>
    </TABLE>
    <DIV class="normal_font">&nbsp; <strong>Nom de sp&eacute;cialit&eacute;:</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <tr>
      <td align=center class="letter"><A href="../Merk/MP_A.htm" class="letterlink">&nbsp;A&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_B.htm" class="letterlink">&nbsp;B&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_C.htm" class="letterlink">&nbsp;C&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_D.htm" class="letterlink">&nbsp;D&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_E.htm" class="letterlink">&nbsp;E&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_F.htm" class="letterlink">&nbsp;F&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_G.htm" class="letterlink">&nbsp;G&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_H.htm" class="letterlink">&nbsp;H&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_I.htm" class="letterlink">&nbsp;I&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_J.htm" class="letterlink">&nbsp;J&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_K.htm" class="letterlink">&nbsp;K&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_L.htm" class="letterlink">&nbsp;L&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_M.htm" class="letterlink">&nbsp;M&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_N.htm" class="letterlink">&nbsp;N&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_O.htm" class="letterlink">&nbsp;O&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_P.htm" class="letterlink">&nbsp;P&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Q.htm" class="letterlink">&nbsp;Q&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_R.htm" class="letterlink">&nbsp;R&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_S.htm" class="letterlink">&nbsp;S&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_T.htm" class="letterlink">&nbsp;T&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_U.htm" class="letterlink">&nbsp;U&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_V.htm" class="letterlink">&nbsp;V&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_W.htm" class="letterlink">&nbsp;W&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_X.htm" class="letterlink">&nbsp;X&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Y.htm" class="letterlink">&nbsp;Y&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Z.htm" class="letterlink">&nbsp;Z&nbsp;</A></td>
     </tr>
    </table>
    <DIV class="normal_font">&nbsp; <strong>Principe actif</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <TR>
      <TD Class="letter" Align="center"><A HRef="../Stof/IN_A.htm" Class="letterlink">&nbsp;A&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_B.htm" Class="letterlink">&nbsp;B&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_C.htm" Class="letterlink">&nbsp;C&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_D.htm" Class="letterlink">&nbsp;D&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_E.htm" Class="letterlink">&nbsp;E&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_F.htm" Class="letterlink">&nbsp;F&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_G.htm" Class="letterlink">&nbsp;G&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_H.htm" Class="letterlink">&nbsp;H&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_I.htm" Class="letterlink">&nbsp;I&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_J.htm" Class="letterlink">&nbsp;J&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_K.htm" Class="letterlink">&nbsp;K&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_L.htm" Class="letterlink">&nbsp;L&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_M.htm" Class="letterlink">&nbsp;M&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_N.htm" Class="letterlink">&nbsp;N&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_O.htm" Class="letterlink">&nbsp;O&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_P.htm" Class="letterlink">&nbsp;P&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Q.htm" Class="letterlink">&nbsp;Q&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_R.htm" Class="letterlink">&nbsp;R&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_S.htm" Class="letterlink">&nbsp;S&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_T.htm" Class="letterlink">&nbsp;T&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_U.htm" Class="letterlink">&nbsp;U&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_V.htm" Class="letterlink">&nbsp;V&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_W.htm" Class="letterlink">&nbsp;W&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_X.htm" Class="letterlink">&nbsp;X&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Y.htm" Class="letterlink">&nbsp;Y&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Z.htm" Class="letterlink">&nbsp;Z&nbsp;</A></TD>
     </TR>
    </TABLE>

   </TD>
<!--- einde van linker "tafel" met TOC --->

<!--- tussen kolommetje --->
   <TD Width="20"></TD>

<!--- begin van rechter "tafel" met ThGrp en M info --->
   <TD vAlign="top">
   
    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR> 
      <TD RowSpan="2" Width="10"></TD>
      <TD Width="70%"><STRONG><FONT Face="Arial" Size="2">R&eacute;pertoire Comment&eacute; des M&eacute;dicaments</FONT></STRONG></TD> 
      <TD Width="29%" Align="Right" Class= "Datum">&nbsp;
       Avril 2015&nbsp;&nbsp;
      </TD>
      <TD Rowspan="2" Width="10"></TD>
     </TR>
     <TR>
      <TD Colspan="2"><HR Width="100%" Size="1" Color="green" NOSHADE></TD>
     </TR>
    </TABLE>

    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR>
      <TD Width="10"><A Name="TiCv00476"></A>&nbsp;</TD>
      <TD><H2>Androg&egrave;nes et st&eacute;ro&iuml;des anabolisants</H2></TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
     <TR>
      <TD Width="10">&nbsp;</TD>
      <TD vAlign="top">
<!---    Start van de HYR->INTRO informatie blok--->
<P Class="Text">Les androg&egrave;nes naturels testost&eacute;rone et antrostanolone (plus disponible en sp&eacute;cialit&eacute;) sont partiellement m&eacute;tabolis&eacute;s lors du premier passage h&eacute;patique.</P>
<A Name="Topic_A"><B>Positionnement</B></A><UL Class="Text"> <LI Class="Text">Pour la nandrolone, l'effet anabolisant est plus prononc&eacute; que l'effet androg&eacute;nique. L'utilisation de la nandrolone en cas de cachexie ou en p&eacute;riode postop&eacute;ratoire est discutable.</LI> <LI Class="Text">En ce qui concerne l'utilisation de d&eacute;hydro&eacute;piandrost&eacute;rone (DHEA), non disponible comme sp&eacute;cialit&eacute; en Belgique, on ne dispose pas de preuves scientifiques suffisamment rigoureuses de son utilit&eacute;, sauf peut-&ecirc;tre chez les femmes atteintes d'une insuffisance surr&eacute;nale (maladie d'Addison) ou d'une insuffisance hypophysaire.</LI></UL>
<A Name="Topic_B"><B>Indications</B></A><UL Class="Text"> <LI Class="Text">Androg&egrave;nes <UL Class="Text"> <LI Class="Text">Traitement de substitution dans l'hypogonadisme m&acirc;le.</LI> <LI Class="Text">Hypopituitarisme.</LI> <LI Class="Text">Retard de croissance et de d&eacute;veloppement en cas de retard pubertaire.</LI> <LI Class="Text">Impuissance par d&eacute;ficience androg&eacute;nique.</LI></UL></LI> <LI Class="Text">Anabolisants (nandrolone) <UL Class="Text"> <LI Class="Text">Bilan azot&eacute; n&eacute;gatif, p. ex. apr&egrave;s des maladies d&eacute;bilitantes, des traumatismes, des interventions chirurgicales: indication discutable.</LI></UL></LI></UL>
<A Name="Topic_C"><B>Contre-indications principales</B></A><UL Class="Text"> <LI Class="Text"><B>Grossesse et allaitement.</B></LI> <LI Class="Text">Insuffisance h&eacute;patique s&eacute;v&egrave;re.</LI> <LI Class="Text">Carcinome de la prostate.</LI></UL>
<A Name="Topic_D"><B>Effets ind&eacute;sirables principaux</B></A><UL Class="Text"> <LI Class="Text">Action virilisante chez la femme et le sujet pr&eacute;pub&egrave;re, en fonction de la pr&eacute;paration et de la dose utilis&eacute;e, parfois aussi avec des doses tr&egrave;s faibles. Risque de transfert de testost&eacute;rone par la peau lors de l'utilisation de gels de testost&eacute;rone [voir Folia de juin 2011].</LI> <LI Class="Text">Fermeture pr&eacute;matur&eacute;e des cartilages de conjugaison chez l'enfant, avec arr&ecirc;t de la croissance.</LI> <LI Class="Text">Augmentation de la libido, priapisme.</LI> <LI Class="Text">Atrophie testiculaire ou oligospermie, infertilit&eacute; masculine, gyn&eacute;comastie.</LI> <LI Class="Text">R&eacute;tention hydrosod&eacute;e.</LI> <LI Class="Text">&Eacute;rythrocytose augmentant la viscosit&eacute; sanguine, ce qui comporte un risque de complications thromboemboliques, surtout chez les personnes &agrave; risque (personnes &acirc;g&eacute;es) et en cas de doses supraphysiologiques.</LI> <LI Class="Text">Augmentation du volume de la prostate, acc&eacute;l&eacute;ration de la progression du cancer de la prostate.</LI> <LI Class="Text">Troubles h&eacute;patiques, parfois avec ict&egrave;re cholestatique.</LI> <LI Class="Text">Avec les formes cutan&eacute;es: aussi des r&eacute;actions locales (&eacute;ryth&egrave;me, prurit) au site d'application.</LI></UL>
<A Name="Topic_T"><B>Grossesse et allaitement</B></A><UL Class="Text"> <LI Class="Text"><B>La grossesse et l'allaitement sont des contre-indications.</B></LI></UL>
<A Name="Topic_E"><B>Interactions principales</B></A><UL Class="Text"> <LI Class="Text">Augmentation de l'effet des antagonistes de la vitamine K.</LI></UL>
<A Name="Topic_F"><B>Pr&eacute;cautions principales</B></A><UL Class="Text"> <LI Class="Text">La prudence s'impose si une r&eacute;tention hydrosod&eacute;e constitue un risque.</LI> <LI Class="Text">Lors d'un traitement prolong&eacute;, un contr&ocirc;le r&eacute;gulier des taux de PSA s'impose.</LI></UL>
<A Name="Topic_W"><B>Administration et posologie</B></A><UL Class="Text"> <LI Class="Text">Les androg&egrave;nes et les st&eacute;ro&iuml;des anabolisants sont utilis&eacute;s par voie cutan&eacute;e (sous forme de gel), par voie intramusculaire sous forme d'esters &agrave; action prolong&eacute;e ou par voie orale. La biodisponibilit&eacute; apr&egrave;s prise orale est faible. Les concentrations syst&eacute;miques obtenues apr&egrave;s administration par voie cutan&eacute;e sont variables.</LI> <LI Class="Text">Seule la posologie usuelle de substitution dans l'hypogonadisme est mentionn&eacute;e.</LI></UL>
<!---    Start van de MP blok(ken)--->
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv00478"></A><A Name="MPG_ECEA"><B>Mest&eacute;rolone</B></A></P>

       <BR>
       <A Name="MP_01411"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Proviron
         <FONT Class="IR_MPG">(Bayer)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[mest&eacute;rolone]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr.</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE084217&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE084217&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEA.htm#Vos_01747" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 0073452<BR><B>CTI</B>: 084217<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">50 x&nbsp;25mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 10,49</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>50 &agrave; 75 mg p.j. en 2 &agrave; 3 prises</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv00479"></A><A Name="MPG_ECEB"><B>Nandrolone</B></A></P>

       <BR>
       <A Name="MP_01414"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Deca-Durabolin
         <FONT Class="IR_MPG">(Aspen)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[nandrolone, d&eacute;canoate]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">amp. i.m.</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE010902&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE010902&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEB.htm#Vos_01887" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2679397<BR><B>CTI</B>: 010902<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">1 x&nbsp;25mg / 1ml </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 4,72</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>&ndash;</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv00480"></A><A Name="MPG_ECEC"><B>Testost&eacute;rone</B></A></P>

       <BR>
       <A Name="MP_01410"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Androgel
         <FONT Class="IR_MPG">(Besins)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">gel (sach.)</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE248437&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE248437&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_05703" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 1795533<BR><B>CTI</B>: 248437<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">30 x&nbsp;50mg / 5g </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 56,50</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>1 sachet p.j. en 1 application sur la peau</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_03371"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Itnogen
         <FONT Class="IR_MPG">(Prostrakan)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">gel doseur</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE292293&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE292293&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_02513" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2399160<BR><B>CTI</B>: 292293<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top"> 60 g&nbsp;20mg / g </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 56,70</TD>
        </TR>
        <TR>
         <TD Width="30">&nbsp;</TD>
         <TD Colspan="4" Class="MppNote_MPG">
&nbsp;&nbsp;(1 pression = 10 mg)</TD>
        </TR>
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>60 mg p.j. en 1 application sur la peau</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_03400"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Nebido
         <FONT Class="IR_MPG">(Bayer)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone, und&eacute;canoate]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">flacon i.m.</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE437132&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE437132&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_02515" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3054269<BR><B>CTI</B>: 437132<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">1 x&nbsp;1g / 4ml </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 116,20</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>1 flacon toutes les 10 &agrave; 14 semaines</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_05303"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Sustanon 250
         <FONT Class="IR_MPG">(Aspen)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone, d&eacute;canoate&nbsp;100mg  + testost&eacute;rone, isocaproate&nbsp;60mg  + testost&eacute;rone, ph&eacute;nylpropionate&nbsp;60mg  + testost&eacute;rone, propionate&nbsp;30mg <B>/ 1,1ml </B>  ]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">amp. i.m.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE012704&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE012704&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_02512" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2736353<BR><B>CTI</B>: 012704<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">1 x 1,1 ml&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/2736353B4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/B4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 10,49</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>1 amp. toutes les 3 semaines</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_02834"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Testim
         <FONT Class="IR_MPG">(Ferring)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">gel</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE269595&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE269595&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_02514" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2194041<BR><B>CTI</B>: 269595<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">30 x&nbsp;50mg / 5g </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 56,69</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>1 &agrave; 2 tubes p.j. en 1 application</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_01413"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Testocaps
         <FONT Class="IR_MPG">(MSD)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Anabolisants, interdits en toutes circonstances')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[testost&eacute;rone, und&eacute;canoate]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">caps.</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE113793&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE113793&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_ECEC.htm#Vos_02516" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 1779032<BR><B>CTI</B>: 113793<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">60 x&nbsp;40mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 32,42</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpPosol_MPG"><I>Posol. </I>40 &agrave; 120 mg p.j. en 2 prises</TD>
        </TR>
       </TABLE>
<!---
       <P Class="datum">
       <A Href="#TopOfPage">
        <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;</P>
--->
      </TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
    </TABLE>
    <BR>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>
<!--- einde van de rechter "tafel" met MP info--->

   </TD>
  </TR>
 </TABLE>
<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
<CFINCLUDE template="/search/incHighLightScriptJQuery.cfm">
